Nebulised interferon as a COVID-19 medicine

Research output: Non-textual formWeb publication/siteProfessional


In a small clinical study conducted in April and May 2020, British scientists investigated the effect of inhalation of nebulised interferon-beta-1a (SNG001) on the development of COVID-19 in patients. The results are encouraging and justify further research.
Translated title of the contributionVerneveld interferon als COVID-19 medicijn
Original languageEnglish
Media of outputOnline
Publication statusPublished - 27 Dec 2020


Dive into the research topics of 'Nebulised interferon as a COVID-19 medicine'. Together they form a unique fingerprint.

Cite this